Bcal Diagnostics Ltd (BDX) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.999x

Based on the latest financial reports, Bcal Diagnostics Ltd (BDX) has a cash flow conversion efficiency ratio of -0.999x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-2.50 Million ≈ $-1.77 Million USD) by net assets (AU$2.50 Million ≈ $1.77 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Bcal Diagnostics Ltd (BDX) balance sheet quality index to measure how much of total assets are equity-financed.

Bcal Diagnostics Ltd - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how Bcal Diagnostics Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check BDX capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.

Bcal Diagnostics Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bcal Diagnostics Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Galileo Mining Ltd AU:GAL	-0.001x
Bright Scholar Education Holdings Ltd Class A NYSE:BEDU	-0.021x
MMAG Holdings Bhd KLSE:0034	0.684x
NORTHERN FREEGOLD F:8N6	-0.086x
Lipocine Inc NASDAQ:LPCN	-0.099x
SDN Company. Ltd KQ:099220	0.012x
Aerometrex Ltd AU:AMX	0.254x
Bravada Gold Corporation V:BVA	-0.213x

Annual Cash Flow Conversion Efficiency for Bcal Diagnostics Ltd (2017–2024)

The table below shows the annual cash flow conversion efficiency of Bcal Diagnostics Ltd from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Bcal Diagnostics Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	AU$6.22 Million ≈ $4.40 Million	AU$-6.14 Million ≈ $-4.34 Million	-0.986x	-87.28%
2023-12-31	AU$8.59 Million ≈ $6.08 Million	AU$-4.52 Million ≈ $-3.20 Million	-0.527x	+54.60%
2022-12-31	AU$5.21 Million ≈ $3.69 Million	AU$-6.05 Million ≈ $-4.28 Million	-1.160x	-247.35%
2021-12-31	AU$9.64 Million ≈ $6.82 Million	AU$-3.22 Million ≈ $-2.28 Million	-0.334x	+0.16%
2020-12-31	AU$3.61 Million ≈ $2.55 Million	AU$-1.21 Million ≈ $-853.62K	-0.334x	+77.81%
2019-12-31	AU$438.92K ≈ $310.56K	AU$-661.65K ≈ $-468.16K	-1.507x	-40.18%
2018-12-31	AU$488.20K ≈ $345.43K	AU$-525.01K ≈ $-371.48K	-1.075x	-118.70%
2017-12-31	AU$-81.85K ≈ $-57.91K	AU$-470.81K ≈ $-333.13K	5.752x	--

About Bcal Diagnostics Ltd

AU:BDX Australia Diagnostics & Research

Market Cap

$17.48 Million

AU$24.70 Million AUD

Market Cap Rank

#25490 Global

#1103 in Australia

Share Price

AU$0.07

Change (1 day)

-4.29%

52-Week Range

AU$0.05 - AU$0.14

All Time High

AU$0.25